Cited by 198Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesGrowth Hormone and Insulin-like Growth Factors

Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin

Open access
Havel, Peter J., Uriu-Hare, Janet Y., Liu, Tina, Stanhope, Kimber L., Stern, Judith S., Keen, Carl L., Ahrén, Bo·1998·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Abstract

Evidence for regulation of circulating leptin by insulin is conflicting. Diabetes was induced in rats with streptozotocin (STZ; 40 mg ⋅ kg−1⋅ day−1× 2 days) to examine the effect of insulin-deficient diabetes and insulin treatment on circulating leptin. After 12 wk, plasma leptin concentrations in untreated rats were all <0.4 ng/ml versus 4.9 ± 0.9 ng/ml in control animals ( P < 0.005). In rats treated with subcutaneous insulin implants for 12 wk, which reduced hyperglycemia by ∼50%, plasma leptin was 2.1 ± 0.6 ng/ml, whereas leptin concentrations were 6.0 ± 1.6 ng/ml in insulin-implanted rats receiving supplemental injections of insulin for 4 days to normalize plasma glucose ( P< 0.005 vs. STZ untreated). In a second experiment, plasma leptin was monitored at biweekly intervals during 12 wk of diabetes. In rats treated with insulin implants, plasma leptin concentrations were inversely proportional to glycemia ( r= −0.64; P < 0.0001) and unrelated to body weight ( P = 0.40). In a third experiment, plasma leptin concentrations were examined very early after the induction of diabetes. Within 24 h after STZ injection, plasma insulin decreased from 480 ± 30 to 130 ± 10 pM ( P < 0.0001), plasma glucose increased from 7.0 ± 0.2 to 24.8 ± 0.5 mM, and plasma leptin decreased from 3.2 ± 0.2 to 1.2 ± 0.1 ng/ml (Δ = −63 ± 3%, P < 0.0001). In a subset of diabetic rats treated with insulin for 2 days, glucose decreased to 11.7 ± 3.9 mM and leptin increased from 0.5 ± 0.1 to 2.9 ± 0.6 ng/ml ( P< 0.01) without an effect on epididymal fat weight. The change of leptin was correlated with the degree of glucose lowering ( r = 0.75, P < 0.05). Thus insulin-deficient diabetes produces rapid and sustained decreases of leptin that are not solely dependent on weight loss, whereas insulin treatment reverses the hypoleptinemia. We hypothesize that decreased glucose transport into adipose tissue may contribute to decreased leptin production in insulin-deficient diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpregu.1998.274.5.r1482

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • At least some beneficial effects of insulin treatment in uncontrolled insulin-deficient diabetes may arise from an associated increase of leptin action because plasma leptin levels are normalized by insulin treatment in uDM rats.

    “at least some of the beneficial effects of insulin treatment may in fact arise from an associated increase of leptin action since plasma leptin levels are normalized by insulin treatment in uDM rats (78).”
  • Uncontrolled insulin-deficient diabetes is characterized by hyperglycemia and hyperphagia, progressive loss of body fat stores, and dramatic reduction of circulating leptin and insulin.

    “uDM is characterized by both hyperglycemia and hyperphagia (102), with progressive loss of body fat stores, and with a dramatic reduction of circulating levels of leptin as well as insulin (78).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Havel, P. J., Uriu-Hare, J. Y., Liu, T., Stanhope, K. L., Stern, J. S., Keen, C. L., & Ahrén, B.
Affiliations
  • Lund University (SE)
  • Department of Nutrition, University of California, Davis, California 95616; and Department of Medicine, Lund University, S-20502 Malmö, Sweden
Venue
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Published
1998-05-01
Volume
274
Issue
5
Pages
R1482-R1491
ISSN
  • 0363-6119 (ISSN-L)
  • 1522-1490
OpenAlex
W2112457773
Cited by
198
References
45
Citations by year
2024: 2 · 2023: 4 · 2021: 8 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 1 · 2016: 8 · 2015: 13 · 2014: 7 · 2013: 10 · 2012: 10
FWCI
4.84
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (5r01dk018899-18)
  • Medical Research Council
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-07355, T32DK007355, DK 50129, R01DK050129, DK-18899)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
leptin, insulin, streptozotocin-induced diabetes, insulin deficiency, insulin therapy, plasma leptin concentration, glycemia, hyperglycemia, leptin regulation, insulin resistance, epididymal adipose tissue, body weight, diabetes reversal, leptin resistance, adipose tissue, energy homeostasis, rats, mice
MeSH terms
Animals, Blood Glucose, Body Weight, Diabetes Mellitus, Experimental, Eating, Hypoglycemic Agents, Insulin, Male, Proteins, Streptozocin, Rats, Sprague-Dawley, Leptin, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review